Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine

Title: Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine
Authors: Avagimyan A.; Pogosova N.; Fogacci F.; Aghajanova E.; Djndoyan Z.; Patoulias D.; Sasso L. L.; Bernardi M.; Faggiano A.; Mohammadifard N.; Neglia D.; Carugo S.; Cicero A.; Rizzo M.; Biondi-Zoccai G.; De Caterina R.; Sarrafzadegan N.
Contributors: Avagimyan, A.; Pogosova, N.; Fogacci, F.; Aghajanova, E.; Djndoyan, Z.; Patoulias, D.; Sasso, L. L.; Bernardi, M.; Faggiano, A.; Mohammadifard, N.; Neglia, D.; Carugo, S.; Cicero, A.; Rizzo, M.; Biondi-Zoccai, G.; De Caterina, R.; Sarrafzadegan, N.
Publication Year: 2025
Collection: IRIS Università degli Studi di Bologna (CRIS - Current Research Information System)
Subject Terms: Cardiodiabetology; Cardiovascular risk; Glucose; Triglyceride-glucose index; Triglyceride; TyG
Description: In the period of increasing prevalence of metabolic disorders such as obesity and diabetes, healthcare professionals are facing significant challenges. Therefore, an accurate global assessment of insulin resistance is of utmost importance. Current medical research is focused on identifying an easily accessible and reproducible gold-standard surrogate marker for insulin resistance. Ideally, such a marker would enable healthcare providers to predict the risk of type 2 diabetes and cardiovascular diseases. The triglyceride-glucose index (TyG) is a promising marker for preventive cardiology and cardiometabolic medicine. This narrative review article aims to provide a comprehensive evaluation of the credibility of TyG as a surrogate marker of insulin resistance among patients at different stages across the cardiometabolic continuum. This assessment fully complies with evidence-based medicine and offers valuable insight into the clinical utility of TyG.
Document Type: article in journal/newspaper
File Description: STAMPA
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/39426418; info:eu-repo/semantics/altIdentifier/wos/WOS:001346223500001; volume:418; firstpage:1; lastpage:13; numberofpages:13; journal:INTERNATIONAL JOURNAL OF CARDIOLOGY; https://hdl.handle.net/11585/1002515; https://internationaljournalofcardiology.com/retrieve/pii/S0167527324012853
DOI: 10.1016/j.ijcard.2024.132663
Availability: https://hdl.handle.net/11585/1002515; https://doi.org/10.1016/j.ijcard.2024.132663; https://internationaljournalofcardiology.com/retrieve/pii/S0167527324012853
Rights: info:eu-repo/semantics/openAccess ; license:Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND) ; license uri:iris.PUB17
Accession Number: edsbas.48C2F354
Database: BASE